Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-01-24 @ 5:41 PM
Study NCT ID:
NCT03108495
Status:
TERMINATED
Last Update Posted:
2025-09-17
First Post:
2017-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Sponsor:
Iovance Biotherapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-22
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-27
First Submit QC Date:
None
Study First Post Date:
2017-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-17
Last Update Post Date Type:
ESTIMATED